Usana Health Sciences
USNA
144 hedge funds and large institutions have $628M invested in Usana Health Sciences in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 23 closing their positions.
24% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 42
4% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 23
1% less funds holding
Funds holding: 145 → 144 (-1)
0.91% less ownership
Funds ownership: 45.46% → 44.55% (-0.91%)
2% less call options, than puts
Call options by funds: $4.68M | Put options by funds: $4.75M
12% less capital invested
Capital invested by funds: $714M → $628M (-$86.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$10.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$2.39M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.37M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.12M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$7.68M |
| 2 |
AP
AHL Partners
London,
United Kingdom
|
-$5.76M |
| 3 |
Morgan Stanley
New York
|
-$4.97M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.68M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.48M |
USNA Hedge Fund Activity: Q3 2017 in Review
144 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q3 2017, worth a combined $628M — down 12% from $714M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new USNA positions and 23 closed out — a net gain of 1 holder — while 52 added to existing stakes and 42 trimmed.
The largest buyer was Norges Bank, adding an estimated $10.1M. The largest seller was Two Sigma Investments, cutting an estimated $7.68M.
- 144 institutional investors held Usana Health Sciences (USNA) as of Q3 2017, down from 145 in Q2 2017.
- Funds reported $628M of Usana Health Sciences stock for Q3 2017, down 12% quarter-over-quarter.
- 24 funds opened new Usana Health Sciences positions in Q3 2017 and 23 closed out, a net change of +1 holder.
- The largest Usana Health Sciences buyer in Q3 2017 was Norges Bank, an estimated $10.1M added.
- The largest Usana Health Sciences seller in Q3 2017 was Two Sigma Investments, an estimated $7.68M sold.
Based on aggregated 13F filings for Q3 2017.